Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Shao

Showing results (981-990 of 1,142) with videos related to

Pageof 115
Sort By:
Cancer Research|August 18, 2025
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast CancerXiu-Zhi Zhu, Hu-Yun-Long Zhang, Yi-Fan Zhou, et al.
Translational Neurodegeneration|February 12, 2015
Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland ChinaWei Chen, Qin Xiao, Ming Shao, et al.
Nature Communications|August 22, 2023
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancerLei-Jie Dai, Ding Ma, Yu-Zheng Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II TrialJun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng, et al.
Medicine|May 29, 2015
Genetic Characteristics of CRF01_AE Among Newly Diagnosed HIV-1-Infected 16- to 25-Year Olds in 3 Geographic Regions of Guangxi, ChinaJing Zhang, Zhi-Yong Shen, Zheng Li, et al.
Gene|February 27, 2022
Identification of thrombin as a key regulator of chondrocyte catabolic activity through RNA-Seq and experimental verificationXi-Chen Wu, Zhi-Heng Zhu, Jun-Peng Zhang, et al.
The Oncologist|May 15, 2020
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical RelevanceShen Zhao, Ding Ma, Yi Xiao, et al.
Diabetes Care|December 9, 2020
Association of Plasma Leucine-Rich α-2 Glycoprotein 1, a Modulator of Transforming Growth Factor-β Signaling Pathway, With Incident Heart Failure in Individuals With Type 2 DiabetesJian-Jun Liu, Sharon L T Pek, Jiexun Wang, et al.
Breast Cancer Research and Treatment|November 13, 2004
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaHe-Cheng Li, Dao-Cheng Cao, Yi Liu, et al.
The Laryngoscope|November 25, 2021
Pathogens and Prognosis of Deep Neck Infection in End-Stage Renal Disease PatientsMing-Shao Tsai, Yao-Hsu Yang, Tsung-Yu Huang, et al.
Pageof 115

Showing results (981-990 of 1,142) with videos related to

Sort By:
Pageof 115
Cancer Research|August 18, 2025
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast CancerXiu-Zhi Zhu, Hu-Yun-Long Zhang, Yi-Fan Zhou, et al.
Translational Neurodegeneration|February 12, 2015
Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland ChinaWei Chen, Qin Xiao, Ming Shao, et al.
Nature Communications|August 22, 2023
Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancerLei-Jie Dai, Ding Ma, Yu-Zheng Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II TrialJun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng, et al.
Medicine|May 29, 2015
Genetic Characteristics of CRF01_AE Among Newly Diagnosed HIV-1-Infected 16- to 25-Year Olds in 3 Geographic Regions of Guangxi, ChinaJing Zhang, Zhi-Yong Shen, Zheng Li, et al.
Gene|February 27, 2022
Identification of thrombin as a key regulator of chondrocyte catabolic activity through RNA-Seq and experimental verificationXi-Chen Wu, Zhi-Heng Zhu, Jun-Peng Zhang, et al.
The Oncologist|May 15, 2020
Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical RelevanceShen Zhao, Ding Ma, Yi Xiao, et al.
Diabetes Care|December 9, 2020
Association of Plasma Leucine-Rich α-2 Glycoprotein 1, a Modulator of Transforming Growth Factor-β Signaling Pathway, With Incident Heart Failure in Individuals With Type 2 DiabetesJian-Jun Liu, Sharon L T Pek, Jiexun Wang, et al.
Breast Cancer Research and Treatment|November 13, 2004
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaHe-Cheng Li, Dao-Cheng Cao, Yi Liu, et al.
The Laryngoscope|November 25, 2021
Pathogens and Prognosis of Deep Neck Infection in End-Stage Renal Disease PatientsMing-Shao Tsai, Yao-Hsu Yang, Tsung-Yu Huang, et al.
Pageof 115